Učitavanje...
ATIM-31. PHASE I STUDY OF TUMOR TREATMENT FIELDS AND A PERSONALIZED MUTATION-DERIVED TUMOR VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
The tumor microenvironment of a glioblastoma is highly immunosuppressive. Overcoming this immunosuppressive activity seems imperative to a successful treatment. Like other cancers, glioblastoma is capable of generating tumor-specific peptides that can be recognized by the immune system, providing a...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216136/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.026 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|